NCT02172157View on ClinicalTrials.gov

Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

April 30, 2008

Conditions
Healthy
Interventions
DRUG

BI 1744 CL i.v.

DRUG

BI 1744 CL oral

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY